Nightcone Labs runs structured, single-variable oneirogen testing: experiments on oneirogens, the compounds reported to alter dreams and dream content. Our oneirogen reviews publish what actually changes, including the nights that nothing does.
The project
Dreaming is one of the last common human experiences that remains poorly instrumented. We sleep, dream, and most of it is gone by breakfast. A long list of historical and ethnobotanical traditions claim that certain plants and compounds, referred to as oneirogens, can change that: sharpen recall, intensify the imagery, or tip a sleeper into lucidity. The clinical literature, by contrast, is thin. There are a handful of controlled trials at sleep labs, a great deal of folk anecdotes, and essentially no clean answers.
Nightcone exists to fill that gap. The premise is simple and deliberately methodical: take one compound at a time, hold the protocol fixed, run it for long enough to separate signal from a noisy baseline, and record the result whether or not it's interesting. This is oneirogen testing done in the open, and the write-ups double as plain-spoken oneirogen reviews. The methodology is shared. Tests are sourced from traditions such as dream practice or divination cultures that named these plants. The results are intended to speak to biohackers, sleep enthusiasts, and the dream curious.
The output is a growing record: a matrix of compounds, doses, protocols, and outcomes that compounds over time into an encyclopedia of dream modification. The future state goal is for the user to be able to choose a desired dream result, and be able to understand what chemistry is needed to achieve that goal.
How the work is run
Every oneirogen is tested on its own on a chemical basis. Tests include no stacking, no behavioral techniques layered in, and no dream journaling unless it's the thing being tested. The point is to isolate the chemical impact first. If an effect appears, it should be attributable to one input.
Protocols run for at least seven consecutive nights at a fixed dose and fixed timing, with a washout when relevant. Dreams vary wildly night to night, so a single trial proves almost nothing. Some compounds have build-up effects versus acute ones, so an extended protocol helps capture these subtle signals.
Most things in this category, tested skeptically, don't do much. Compounds that produce nothing get the same write-up as the ones that work. A documented null effect saves an identical multi-night test.
Where a pathway is plausible, such as cholinergic compounds and REM, it's stated with its level of validation. We are not inventing mechanisms, and don't promise outcomes the evidence can't support.
The matrix
This is the Nightcone oneirogen testing matrix, the running record behind every oneirogen review we publish. Every compound tested is a row: substance, scientific name, cultural tradition, dose, preparation, and whether it produced a lucid dream. The matrix is the central, cumulative artifact; individual videos are just how each row gets reported.
| Entry | Substance | Scientific name | Cultural tradition | Lucidity? | Dose | Preparation | Tags | Impact |
|---|---|---|---|---|---|---|---|---|
| 001 | Silene Capensis | Silene Capensis | Ubulawu / Zulu / Xhosa | — | — | foam, morning, empty stomach | ubulawu | low |
| 002 | Mexican Dream Herb | Calea zacatechichi | Chontal | Y | — | — | — | low |
| 003 | Synaptolepis kirkii | Synaptolepis kirkii | Ubulawu / Zulu / Xhosa | — | — | foam, morning, empty stomach | ubulawu | low |
| 004 | Mugwort | Artemisia vulgaris | — | Y | 2g | tea, pre-bed | — | low |
| 005 | Galantamine | Galanthus nivalis | Western Medicine | Y | 8mg | WBTB | cholinergic | high |
| 006 | Huperzine A | Huperzia serrata | Eastern Medicine | — | 200 and 400mcg | WBTB | cholinergic | low |
| 007 | Blue Lotus | Nymphaea caerulea | Egyptian | — | 5g | tea, pre-bed, WBTB | — | null |
| 008 | African Fever Tree | Vachellia xanthophloea | Ubulawu / Zulu / Xhosa | — | 2g | tea, pre-bed, WBTB | ubulawu | null |
| 009 | Alpha-GPC | L-Alpha-glycerylphosphorylcholine | NA | — | 600mg | WBTB | cholinergic | null |
| 010 | Mexican Tarragon | Tagetes lucida | Aztec | — | 2g | tea, pre-bed | — | null |
| 011 | Celastrus paniculatus | Celastrus paniculatus | Ayurvedic | — | 2g | blended in oil, pre-bed | cholinergic | low |
Lucidity (Y) marks runs where a lucid dream occurred. The matrix grows with every entry.
Where we stand
Publishing null and ambiguous findings transparently. Mechanism-forward framing over dosage-forward. Treating the matrix as a compounding public artifact. Restraint as a stance, not an afterthought.
Mysticism and wellness softness. Hype marketing and guaranteed outcomes. Stacking recommendations. Anything sold as a cure. This is a record, not a product.
Not medical advice. Nightcone documents self-experimentation for research interest. Compounds discussed can carry real toxicity and interaction risks. Nothing here is a recommendation to ingest anything.
Results from controlled oneirogen experiments. What impacted dreaming, what didn't, and topical news. New tests each cycle.